Anthem Blue Cross and Blue Shield Nevada prior authorization, page 51

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0101UHereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel utilizing aNevada Prior Authorization List, Pg 111 Original policy
0102TExtracorporeal shock wave performed by a physician, requiring anesthesia other than local, and involving the lateral humeral epicondyleNevada Prior Authorization List, Pg 111 Original policy
0102UHereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizingNevada Prior Authorization List, Pg 112 Original policy
0103UHereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and arrNevada Prior Authorization List, Pg 112 Original policy
0105UNephrology (chronic kidney disease), multiplex electrochemiluminescent immunoassay (ECLIA) of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidNevada Prior Authorization List, Pg 112 Original policy
0106TQST TST-EXT; TOUCH PRESS LG DIAM SENSATIONNevada Prior Authorization List, Pg 112 Original policy
0107TQST TST-EXT; VIBRATION LG DIAM FIBER SENSATIONNevada Prior Authorization List, Pg 112 Original policy
0108TQST-EXT; COOL SM NRV FIBR SENSATION&HYPERALGESIANevada Prior Authorization List, Pg 112 Original policy
0108UGastroenterology (Barrett's esophagus), whole slide-digital imaging, including morphometric analysis, computer-assisted quantitative immunolableing of 9 protein biomarkers (p1Nevada Prior Authorization List, Pg 112 Original policy
0109TQST-EXT;HEAT-PAIN SM NRV FIBR SENSATN&HYPRALGSIANevada Prior Authorization List, Pg 112 Original policy
0110TQST TST-EXT; OTHER STIMULI ASSESS SENSATIONNevada Prior Authorization List, Pg 112 Original policy
0111UOncology (colon cancer), targeted KRAS (codons 12, 13, and 61) and NRAS (codons 12, 13, and 61) gene analysis utilizing formalin-fixed paraffin- embedded tissueNevada Prior Authorization List, Pg 112 Original policy
0112UInfectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance geneNevada Prior Authorization List, Pg 112 Original policy
0113UOncology (prostate), measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence- based detection, algorithNevada Prior Authorization List, Pg 112 Original policy
0117UPain management, analysis of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5- hydroxyindoleacetic acid, hydroxyNevada Prior Authorization List, Pg 112 Original policy
0118UTransplantation medicine, quantification of donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-freNevada Prior Authorization List, Pg 112 Original policy
0120UOncology (B-cell lymphoma classification), mRNA, gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes), formalin-fixeNevada Prior Authorization List, Pg 112 Original policy
0129UHereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis and deletion/dupNevada Prior Authorization List, Pg 112 Original policy
0130UHereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), targeted mRNA sequence analysis panel (APCNevada Prior Authorization List, Pg 112 Original policy
0134UHereditary pan cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (18 genes)Nevada Prior Authorization List, Pg 112 Original policy
0136UATM (ataxia telangiectasia mutated) (eg, ataxia telangiectasia) mRNA sequence analysis (List separately in addition to code for primary procedure)Nevada Prior Authorization List, Pg 112 Original policy
0138UBRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to coNevada Prior Authorization List, Pg 112 Original policy
0152UInfectious disease (bacteria, fungi, parasites, and DNA viruses), microbial cell- free DNA, plasma, untargeted next-generation sequencing, report for significant positive pathoNevada Prior Authorization List, Pg 112 Original policy
0153UOncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triplNevada Prior Authorization List, Pg 112 Original policy
0154UOncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], pNevada Prior Authorization List, Pg 112 Original policy
0155UOncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, breast cancer) gene analysis (ie, p.C420R, p.E542K, p.E545Nevada Prior Authorization List, Pg 113 Original policy
0156UCopy number (eg, intellectual disability, dysmorphology), sequence analysisNevada Prior Authorization List, Pg 113 Original policy
0163TTotal disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression), each additional interspace, lumbar (LiNevada Prior Authorization List, Pg 113 Original policy
0164TRemoval of total disc arthroplasty, (artificial disc), anterior approach, each additional interspace, lumbar (List separNevada Prior Authorization List, Pg 113 Original policy
0164UGastroenterology (irritable bowel syndrome [IBS]), immunoassay for anti-CdtB and anti-vinculin antibodies, utilizing plasma, algorithm for elevated or not elevated qualitativeNevada Prior Authorization List, Pg 113 Original policy
0165TRevision including replacement of total disc arthroplasty (artificial disc), anterior approach, each additional interspaNevada Prior Authorization List, Pg 113 Original policy
0166ULiver disease, 10 biochemical assays (+2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, GGT, ALT, AST, triglycerides, cholesterol, fasting glucose) and biometric aNevada Prior Authorization List, Pg 113 Original policy
0169UNUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variantsNevada Prior Authorization List, Pg 113 Original policy
0170UNeurology (autism spectrum disorder [ASD]), RNA, next-generation sequencing, saliva, algorithmic analysis, and results reported as predictive probability of ASD diagnosisNevada Prior Authorization List, Pg 113 Original policy
0171UTargeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms, DNA analysis, 23 genes, interrogation for sequencNevada Prior Authorization List, Pg 113 Original policy
0172UOncology (solid tumor as indicated by the label), somatic mutation analysis of BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) and analysis of homolNevada Prior Authorization List, Pg 113 Original policy
0173UPsychiatry (ie, depression, anxiety), genomic analysis panel, includes variant analysis of 14 geneNevada Prior Authorization List, Pg 113 Original policy
0174UOncology (solid tumor), mass spectrometric 30 protein targets, formalin-fixed paraffin-embedded tissue, prognostic and predictive algorithm reported as likely, unlikely, or unNevada Prior Authorization List, Pg 113 Original policy
0175UPsychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genesNevada Prior Authorization List, Pg 113 Original policy
0176UCytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)Nevada Prior Authorization List, Pg 113 Original policy
0177UOncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) gene analysis of 11 gene variants utilizing plasma, reported asNevada Prior Authorization List, Pg 113 Original policy
0179UOncology (non-small cell lung cancer), cell-free DNA, targeted sequence analysis of 23 genes (single nucleotide variations, insertions and deletions, fusions without prior knoNevada Prior Authorization List, Pg 113 Original policy
0186TSuprachoroidal delivery of pharmacologic agent (does not include supply of medication)Nevada Prior Authorization List, Pg 113 Original policy
0191TInsertion of anterior segment aqueous drainage device, without extraocular reservoir; internal approach, into the trabecular meshworkNevada Prior Authorization List, Pg 113 Original policy
0192TInsertion of anterior segment aqueous drainage device, without extraocular reservoir; external approachNevada Prior Authorization List, Pg 113 Original policy
0200TPercutaneous sacral augmentation (sacroplasty), unilateral injection(s), including the use of a balloon or mechanical device, when used, 1 or more needlesNevada Prior Authorization List, Pg 113 Original policy
0201TPercutaneous sacral augmentation (sacroplasty), bilateral injections, including the use of a balloon or mechanical device, when used, 2 or more needlesNevada Prior Authorization List, Pg 113 Original policy
0202TPosterior vertebral joint(s) arthroplasty (e.g., facet joint[s] replacement) including facetectomy, laminectomy, foraminNevada Prior Authorization List, Pg 113 Original policy
0203UAutoimmune (inflammatory bowel disease), mRNA, gene expression profiling by quantitative RT-PCR, 17 genes (15 target and 2 reference genes), whole blood, reported as a continuNevada Prior Authorization List, Pg 113 Original policy
0205UOphthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negativNevada Prior Authorization List, Pg 114 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.